References
- Wilson, J. M. N. Engl. J. Med. 1996, 334, 1185 https://doi.org/10.1056/NEJM199605023341809
- Han, S.; Mahato, R. I.; Sung, Y. K.; Kim, S. W. Mol. Ther. 2000, 2, 302 https://doi.org/10.1006/mthe.2000.0142
- Lee, M.; Kim, S. W. Pharm. News 2002, 9, 407
- Kabanov, A. V.; Kabanov, V. A. Bioconjug. Chem. 1995, 6, 7
- Lee, M.; Kim, S. W. Pharm. Res. 2005, 22, 1 https://doi.org/10.1007/s11095-004-9003-5
- Choi, J. S.; Choi, M. J.; Ko, K. S.; Rhee, B. D.; Pak, Y. K.; Bang, I. S.; Lee, M. Bull. Kor. Chem. Soc. 2006, 27, 1335 https://doi.org/10.5012/bkcs.2006.27.9.1335
- Kang, H. C.; Lee, M.; Bae, Y. H. Crit. Rev. Eukaryot. Gene Expr. 2005, 15, 317 https://doi.org/10.1615/CritRevEukarGeneExpr.v15.i4.30
- Boussif, O.; Lezoualc'h, F.; Zanta, M. A.; Mergny, M. D.; Scherman, D.; Demeneix, B.; Behr, J. P. Proc. Natl. Acad. Sci. USA 1995, 92, 7297
- Boussif, O.; Zanta, M. A.; Behr, J. P. Gene Ther. 1996, 3, 1074
- Benns, J. M.; Maheshwari, A.; Furgeson, D. Y.; Mahato, R. I.; Kim, S. W. J. Drug Target 2001, 9, 123 https://doi.org/10.3109/10611860108997923
- Sagara, K.; Kim, S. W. J. Control. Release 2002, 79, 271 https://doi.org/10.1016/S0168-3659(01)00555-7
- Suh, W.; Han, S. O.; Yu, L.; Kim, S. W. Mol. Ther. 2002, 6, 664 https://doi.org/10.1016/S1525-0016(02)90721-5
- Ogris, M.; Brunner, S.; Schuller, S.; Kircheis, R.; Wagner, E. Gene Ther. 1999, 6, 595
- Lim, Y. B.; Han, S. O.; Kong, H. U.; Lee, Y.; Park, J. S.; Jeong, B.; Kim, S. W. Pharm. Res. 2000, 17, 811 https://doi.org/10.1023/A:1007552007765
- Fischer, D.; Bieber, T.; Li, Y.; Elsasser, H. P.; Kissel, T. Pharm. Res. 1999, 16, 1273 https://doi.org/10.1023/A:1014861900478
- Godbey, W. T.; Wu, K. K.; Mikos, A. G. Biomaterials 2001, 22, 471 https://doi.org/10.1016/S0142-9612(00)00203-9
- Kim, Y. H.; Park, J. H.; Lee, M.; Kim, Y. H.; Park, T. G.; Kim, S. W. J. Control. Release 2005, 103, 209 https://doi.org/10.1016/j.jconrel.2004.11.008
- Lee, M.; Rentz, J.; Han, S. O.; Bull, D. A.; Kim, S. W. Gene Ther. 2003, 10, 585 https://doi.org/10.1038/sj.gt.3301938
Cited by
- Cell line specific control of polyethylenimine-mediated transient transfection optimized with “Design of experiments” methodology vol.28, pp.1, 2011, https://doi.org/10.1002/btpr.715
- Amiloride-enhanced gene transfection of octa-arginine functionalized calcium phosphate nanoparticles vol.12, pp.11, 2017, https://doi.org/10.1371/journal.pone.0188347
- Evaluating polyethyleneimine/DNA nanoparticles-mediated damage to cellular organelles using endoplasmic reticulum stress profile pp.2169-141X, 2018, https://doi.org/10.1080/21691401.2017.1304406
- Polyamidoamine (PAMAM) Dendrimers Modified with Cathepsin-B Cleavable Oligopeptides for Enhanced Gene Delivery vol.9, pp.12, 2017, https://doi.org/10.3390/polym9060224
- Macrocycle-wrapped polyethylenimine for gene delivery with reduced cytotoxicity vol.6, pp.5, 2018, https://doi.org/10.1039/C8BM00022K
- Generation of a Focused Poly(amino ether) Library: Polymer-mediated Transgene Delivery and Gold-Nanorod based Theranostic Systems vol.2, pp.12, 2007, https://doi.org/10.7150/thno.4492
- Evaluation and comparison of cytotoxicity, genotoxicity, and apoptotic effects of poly-L-lysine/plasmid DNA micro- and nanoparticles vol.38, pp.8, 2019, https://doi.org/10.1177/0960327119846924